"The Centers for Disease Control estimates that over 200,000 persons are hospitalized and 36,000 persons die each year in the United States due to influenza and its complications. There is currently no drug for influenza that is available as an injection for hospital use and this intravenous formulation of peramivir holds particular promise in this indication."
http://www.medicalnewstoday.com/articles/77727.php
Biocryst got a grant of over US$100 million to trial injectable peramivir, what was GSK doing?
Add to My Watchlist
What is My Watchlist?